CW
CPRX

CreativeOne Wealth’s Catalyst Pharmaceutical CPRX Stock Holding History

CreativeOne Wealth’s Portfolio CPRX Stock Details CPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-34,044
Closed -$739K – 1156
2025
Q2 		$739K Sell
34,044
-2,529
-7% -$59.7K 0.02% 627
2025
Q1 		$887K Sell
36,573
-121
-0.3% -$2.73K 0.03% 521
2024
Q4 		$766K Buy
+36,694
New +$788K 0.02% 558
2023
Q2 		– Sell
-38,313
Closed -$635K – 844
2023
Q1 		$635K Buy
38,313
+5,918
+18% +$97.6K 0.03% 407
2022
Q4 		$603K Buy
+32,395
New +$499K 0.03% 380

Other funds holding CPRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

CreativeOne Wealth's CPRX Position: Q3 2025 in Review

CreativeOne Wealth sold out of Catalyst Pharmaceutical (CPRX) in Q3 2025, closing a stake of 34,044 shares — an estimated $739K sold.

CreativeOne Wealth first reported a position in CPRX in Q4 2022 and held it in 5 quarters. The position peaked at $887K in Q1 2025. 360 funds tracked by Wall St. Rank hold CPRX as of Q3 2025.

  • CreativeOne Wealth reported no remaining Catalyst Pharmaceutical position as of Q3 2025 after selling out during the quarter.
  • CreativeOne Wealth sold 34,044 Catalyst Pharmaceutical shares in Q3 2025, an estimated $739K.
  • CreativeOne Wealth first reported a position in Catalyst Pharmaceutical in Q4 2022 and held it in 5 quarters.
  • CreativeOne Wealth's Catalyst Pharmaceutical position peaked at $887K in Q1 2025.
  • 360 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q3 2025.

Based on CreativeOne Wealth's 13F filing for Q3 2025, filed 13 Nov 2025.